SPI Pharma

Wilmington, United States Founded: 2000 • Age: 26 yrs
Excipient products and formulations are manufactured for pharmaceutical uses.
Request Access

About SPI Pharma

SPI Pharma is a company based in Wilmington (United States) founded in 2000.. The company has 22 employees as of April 05, 2024. SPI Pharma offers products and services including Pharmaburst 500, Mannogem Mannitol, Pharmasperse, and UltraBurst. SPI Pharma operates in a competitive market with competitors including Colorcon, Pfanstiehl, Scope Ingredients, Crest Cellulose and DFE Pharma, among others.

  • Headquarter Wilmington, United States
  • Employees 22 as on 05 Apr, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Spi Specialties Pharma Private Limited
  • Date of Incorporation 05 Dec, 2013
  • Jurisdiction Bengaluru, Karnataka, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $1.11 M (USD)
    22.01
    as on Mar 31, 2022
  • Net Profit
    $126.34 K (USD)
    27.36
    as on Mar 31, 2022
  • EBITDA
    $207.01 K (USD)
    43.26
    as on Mar 31, 2022
  • Latest Funding Round
  • Investors
  • Employee Count
    22

    as on Apr 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of SPI Pharma

SPI Pharma offers a comprehensive portfolio of products and services, including Pharmaburst 500, Mannogem Mannitol, Pharmasperse, and UltraBurst. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enables rapid disintegration for orally disintegrating tablets.

Provides mannitol for efficient tablet formulation and stability.

Offers powder platform for sachets with patient-friendly benefits.

Delivers fast disintegration for tablets with high hardness.

People of SPI Pharma
Headcount 200-500
Employee Profiles 35
Employee Profiles
People
Leila Hirata
LA Technical Sales Manager
People
Niraj Pandey
Sales Manager
People
Sowmya Raghavendra
Aspac Customer Service And Inside Sales Manager
People
Ahmed Ali
Customer Success Specialist

Unlock access to complete

Funding Insights of SPI Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by SPI Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - SPI Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Spi Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of SPI Pharma

SPI Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Colorcon, Pfanstiehl, Scope Ingredients, Crest Cellulose and DFE Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups
domain founded_year HQ Location
APIs, injectable excipients, and bioprocessing solutions are manufactured.
domain founded_year HQ Location
Formulations, warehousing, and logistics services for pharmaceuticals are provided.
domain founded_year HQ Location
Pharmaceutical excipients and food ingredients are developed and manufactured.
domain founded_year HQ Location
Developer and manufacturer of excipients for oral solid dosage forms and dry powder inhalations
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about SPI Pharma

When was SPI Pharma founded?

SPI Pharma was founded in 2000.

Where is SPI Pharma located?

SPI Pharma is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

How many employees does SPI Pharma have?

As of Apr 05, 2024, the latest employee count at SPI Pharma is 22.

What is the annual revenue of SPI Pharma?

Annual revenue of SPI Pharma is $1.11M as on Mar 31, 2022.

What does SPI Pharma do?

SPI Pharma was founded in 2000 and is based in Wilmington, United States. Operations center on the pharmaceutical sector, where excipient products and formulation services are provided. Active ingredients for antacids, calcium powders, and functional excipients are developed, alongside drug delivery systems, taste-masked actives, and vaccine adjuvants. Applications encompass orally disintegrating technology and taste-masking processes.

Who are the top competitors of SPI Pharma?

SPI Pharma's top competitors include Colorcon, DFE Pharma and Crest Cellulose.

What products or services does SPI Pharma offer?

SPI Pharma offers Pharmaburst 500, Mannogem Mannitol, Pharmasperse, and UltraBurst.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available